Back to search

Article

Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response Prediction

2025-06-11

Abstract excerpt

<title>Abstract</title> <p>Background Precision oncology for breast cancer increasingly relies on hematologic biomarkers and artificial intelligence (AI) to enhance risk stratification and predict treatment response. Recent advancements in liquid biopsy technologies and machine learning have significantly accelerated progress in this field since 2020 (Bartolomucci et al., 2025). Methods We conducted a comprehen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c35374d-9cb1-5f14-ae9b-225bba81d6c5
DOI
10.21203/rs.3.rs-6500133/v4
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response PredictionDOI 10.21203/rs.3.rs-6500133/v4
Hematologic Biomarkers and AI in Breast Cancer: A New Frontier for Risk Stratification and Treatment Response PredictionSemantic proximity
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity
Breast cancer biomarkers and molecular medicine.Semantic proximity
Clinical utility of liquid biopsy in breast cancer: A systematic review.Semantic proximity
Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.Semantic proximity
An Ensemble-Base Machine Learning Approach to Predict 2- and 10-Year Breast CancerSemantic proximity
Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity
AI‐Driven Multi‐Omics Integrated Applications Using Diverse Neural Networks for Breast Cancer Diagnostic Screening and Biomarker DiscoverySemantic proximity
Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkersSemantic proximity
The Multi-Omic Transformation of Breast Cancer Diagnostics: A Comprehensive Review of the Transition from Immunohistochemistry to Liquid Biopsy and Next-Generation SequencingSemantic proximity
AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity
Epigenetic profile drives accurate survival prediction in breast cancer via a multi-omics machine learning modelSemantic proximity
Select a neighboring publication to make it the new centre.